Vascular complications in patients with metabolic syndrome;Powikłania naczyniowe u chorych na zespół metaboliczny

Polski Merkuriusz Lekarski

Volumn 30, Issue 178, 2011, Pages 241-245

  Kowalski, Jan ^a   Śliwczyńska Rodziewicz, Dorota ^b   Ciećwierz, Julita ^a   Kowalczyk, Edward ^a   Pawlicki, Lucjan ^a   Irzmańskp, Robert ^a   Mejer, Anna ^a   Szadkowska, Iwona ^a   Barylski, Marcin ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Ophthalmology Ward   (Poland)

Author keywords

Metabolic syndrome; Vascular complications

Indexed keywords

AGED; ARTICLE; COMORBIDITY; DIABETIC FOOT; DIABETIC RETINOPATHY; EPIDEMIOLOGY; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; INCIDENCE; KIDNEY DISEASE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; STROKE; VASCULAR DISEASE;

AGED; CAUSALITY; COMORBIDITY; DIABETIC FOOT; DIABETIC RETINOPATHY; FEMALE; HUMANS; INCIDENCE; KIDNEY DISEASES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MYOCARDIAL ISCHEMIA; STROKE; VASCULAR DISEASES;

EID: 79957486408     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Agrawal R. P., Sharma P., Pal M. i wsp.: Magnitude of dyslipidemia and its association with micro and macrovascular complications in type 2 diabetes: a hospital based study from Bikaner (Northwest India). Diabetes Res. Clin. Pract, 2006, 73, 211-214. (Pubitemid 43928161)
2. Cardoso C. R., Salles G. F.: Predictors of development and progression of microvascular complications in a cohort of Brazilian type 2 diabetic patients. J. Diabetes Complications, 2008, 22, 164-170. (Pubitemid 351539061)
3. Cheung N., Wang J. J., Klein R. i wsp.: Diabetic Retinopathy and the Risk of Coronary Heart Disease. The Atherosclerosis Risk in Communities Study. Diabetes Care, 2007, 30, 1742-1746. (Pubitemid 47036346)
4. M. Dekker J. M., Girman C., Rhodes T. i wsp.: Metabolic Syndrome and 10-Year Cardiovascular Disease Risk in the Hoom Study. Circulation, 2005, 112, 666-673. (Pubitemid 41099045)
5. Ritz R.: Metabolic Syndrome: An Emerging Threat to Renal Function. Clin. J. Am. Soc. Nephrol., 2007, 2, 869-871.
6. Guize L., Thomas F., Pannier B. i wsp.: All-cause mortality associated with specific combinations of the metabolic syndrome according to recent definitions. Diabetes Care, 2007, 30, 2381-2387. (Pubitemid 47364645)
7. Isomaa B., Almgren P., Tuomi T. i wsp.: Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome. Diabetes Care, 2001, 24, 683-689. (Pubitemid 32893993)
8. Jennifer J., Chao J. R., Stanley P., Lai M-Y., Azen S. P., Klein R., Varma R., and the los Angeles Latino Eye Study Group: Retinopathy in Persons without Diabetes: The los Angeles Latino Eye Study. Invest. Ophthalmol. Vis. Sci., 2007, 48, 4019-4025. (Pubitemid 351261024)
9. Juutilainen A., Lehto S., Ronnemaa T. i wsp.: Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women. Diabetes Care, 2007, 30, 292-299. (Pubitemid 46198333)
10. Katharine R. Tuttle.: Renal manifestations of the metabolic syndrome. Nephrol. Dial. Transplant., 2005, 20, 861-864. (Pubitemid 40704018)
11. Kawasaki R., Tielsch J. M., Wang J. J. i wsp.: The metabolic syndrome and retinal microvascular signs in a Japanese population: the Funagata study. Br. J. Ophthalmol., 2008, 92, 161-166. (Pubitemid 351224086)
12. Klein R., Klein B. E. K., Moss S. E.: The relation of systemic hypertension to changes in the retinal vasculature. The Beaver Dam Eye Study. Trans. Am. Ophthalmol. Soc, 1997, 95, 329-350. (Pubitemid 27519953)
13. Kurella M., Lo J. C., Chertow G. M.: Metabolic Syndrome and the Risk for Chronic Kidney Disease among Nondiabetic Adults. J. Am. Soc. Nephrol., 2005, 16, 2134-2140. (Pubitemid 41716445)
14. Kowalski J., Barylski M.: Rozpoznawanie zespoiu metabolicznego, W: Zespół metaboliczny - prewencja i leczenie. Akademia Medyczna, Warszawa, 2007, 45-52.
15. Kowalski J., Barylski M., Ciećwierz J. i wsp.: Charakterystyka zespoiu metabolicznego u pacjentów bez chorób i z chorobami układu sercowonaczyniowego. Pol. Merk. Lek., 2009, 160, 279-283.
16. Kowalski J., Krzemirńska A., Banach M. i wsp.: The concentration of uric acid in patients with metabolic syndrome and cardiovascular diseases. Centr. J. Med., 2009, 4, 272-278.
17. Leiden H. A., Dekker J. M., Moll A. C. i wsp.: Blood pressure, lipids, and obesity are associated with retinopathy: the Hoom study. Diabetes Care, 2002, 25, 1320-1325. (Pubitemid 41071139)
18. Łopatyrńskl J., Szcześniak G., Madarowlcz G.: Chorobowość sercowonaczyniowa u pacjentów z zespoiem metabolicznym w zaleźności od zastosowanych kryteńów diagnostycznych WHO i NCEP-ATP III. Med. Dypl., 2006, wydanie specjalne (supl.), 81, abstract.
19. Madarowicz G., Łopatyńskl J., Szydłowski W., Nicer T.: Zmiana chorobowości sercowo-naczyniowej w zespole metabolicznym w 5-letnim badaniu follow-up. Med. Dypl., 2006, wydanie specjalne (supl.), 81, abstract.
20. Meigs J. B., Wilson P. W., Nathan D. M. i wsp.: Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes, 2003, 52, 2160-2167. (Pubitemid 36919812)
21. Nguyen T. T., Wong T. Y.: Retinal vascular manifestations of metabolic disorders. Trends. Endocrinol. Metab., 2006, 17, 262-268. (Pubitemid 44287473)
22. Nilsson P. M., Engström G., Hedblad B.: The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects - a population-based study comparing three different definitions. Diabetic Medicine, 2007, 4, 464-472. (Pubitemid 46669326)
23. Pasceri V., Willerson J. T., Yeh T.: Cardiovascular morbidity syndrome and mortality associated with the metabolic syndrome. Diabetes Care, 2001, 4, 683-689.
24. Prataap K., Shaw C., Berger S. P. i wsp.: Central Obesity Is an Independent Risk Factor for Albuminuria in Nondiabetic South Asian Subjects. Diabetes Care, 2007, 30, 1840-1844. (Pubitemid 47036361)
25. Sattar N., Gaw G., Scherbakova O. i wsp.: Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation, 2003, 108, 414-419. (Pubitemid 36935533)
26. Wang J. J., Mitchell P., Leung H. i wsp.: Hypertensive retinal vessel wall signs in the general older population: the Blue Mountains Eye Study. Hypertension, 2003, 42, 534-541. (Pubitemid 37237350)
27. Wilczyński M., Omulecki W.: Zarys patogenezy retinopatii cukrzycowej. OFTAL, Warszawa, 2007.
28. Wtodarczyk A., Kuropatnicka H., Szczepanek P. i wsp.: Wystȩpowanie zespołu metabolicznego u chorych z potwierdzona̧ angiograficznie choroba̧ wieńcowa̧ wg różnych definicji. Med. Dypl., 2006, wydanie specjalne (supl.), 78, abstract.
29. Yarneil J. W. G. i wsp.: Lifestyl and hemostatic pisk factors for ischemic hart disease. The Caerphilly Stydy. Aterioscler. Thromb. Vasc. Biol., 2000, 20, 271.
30. Żełobowska K., Gumprecht J., Cierpka L. i wsp.: Powikłania mikro-i makronaczyniowe w cukrzycy. Kardioprofil, 2007, 3, 163-169.